Shenzhen Third People's Hospital

This phase II trial tests an experimental drug called AS1501 in people with acute-on-chronic liver failure (ACLF), a sudden worsening of liver function in those with chronic liver disease. The study first evaluates safety in a small group, then compares the drug against a placebo…

This study tests a new ultra-short treatment for both drug-sensitive and drug-resistant tuberculosis (TB). The goal is to see if a 2-3 month regimen works as well as or better than the standard 4-6 month treatment. About 610 adults with active TB will take part. The approach coul…